Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation for prevention of stroke

W M Feinberg1

  • 1Comprehensive Stroke Program, The University of Arizona Health Sciences Center, Tucson, USA.

Neurology
|September 23, 1998
PubMed
Summary

Warfarin significantly lowers stroke risk in atrial fibrillation (AF) patients by 70%. Risk stratification helps identify those most benefiting from anticoagulation therapy for stroke prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time course of platelet activation following acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.

Stroke·1999
Same author

Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

Thrombosis and haemostasis·1999
Same author

Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke Prevention in Atrial Fibrillation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1999
Same author

Stroke risk in an elderly population with atrial fibrillation.

Journal of general internal medicine·1999
Same author

Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Circulation·1998

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk.
  • Anticoagulation therapy, specifically warfarin, has emerged as a key strategy for stroke prevention in AF patients.
  • Understanding risk stratification is crucial for optimizing treatment decisions.

Purpose of the Study:

  • To summarize the efficacy of warfarin in reducing stroke risk for patients with atrial fibrillation.
  • To highlight the role of risk factors in stratifying stroke risk within the AF population.
  • To discuss the application of anticoagulation in other cardioembolic conditions.

Main Methods:

  • Review of clinical evidence demonstrating warfarin's impact on stroke risk in AF.
  • Analysis of stroke risk based on the presence of additional cardiovascular risk factors.
  • Examination of anticoagulation's benefits in non-AF cardioembolic sources.

Main Results:

  • Anticoagulation with warfarin reduces annual stroke risk in AF patients from 4.5% to 1.5% (a 70% relative risk reduction).
  • Patients with risk factors like prior stroke, hypertension, heart failure, or diabetes have a significantly higher stroke risk (≥8% annually).
  • Low-risk patients (under 75, no risk factors) may benefit from aspirin, while higher-risk patients gain more from anticoagulation.

Conclusions:

  • Warfarin is highly effective in preventing stroke for patients with atrial fibrillation.
  • Risk stratification using factors like age, hypertension, and comorbidities is essential for tailoring anticoagulation therapy.
  • Anticoagulation is also beneficial for stroke prevention in other conditions with cardioembolic potential.

Related Experiment Videos